Zdrowie i gospodarka · 13/04/2011
FDA Proposes Expansion of Clinical Investigator Disqualification Rules
The FDA is proposing to broaden the scope of disqualification for clinical investigators who are ineligible to receive certain test articles, aiming to protect research subjects and data quality.
Source: Federal Register — Health and Human ServicesOpen original release →